Literature DB >> 10864891

Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock.

M C McDonald1, H Mota-Filipe, J A Wright, M Abdelrahman, M D Threadgill, A S Thompson, C Thiemermann.   

Abstract

Poly (ADP-ribose) synthetase (PARP) is a nuclear enzyme activated by strand breaks in DNA, which are caused inter alia by reactive oxygen species (ROS). Here we report on (i) a new synthesis of a water-soluble and potent PARP inhibitor, 5-aminoisoquinolinone (5-AIQ) and (ii) investigate the effects of 5-AIQ on the circulatory failure and the organ injury/dysfunction caused by haemorrhage and resuscitation in the anaesthetized rat. Exposure of human cardiac myoblasts (Girardi cells) to hydrogen peroxide (H(2)O(2), 3 mM for 1 h, n=9) caused a substantial increase in PARP activity. Pre-treatment of these cells with 5-AIQ (1 microM - 1 mM, 10 min prior to H(2)O(2)) caused a concentration-dependent inhibition of PARP activity (IC(50): approximately 0.01 mM, n=6). Haemorrhage and resuscitation resulted (within 4 h after resuscitation) in a delayed fall in blood pressure (circulatory failure) as well as in rises in the serum levels of (i) urea and creatinine (renal dysfunction), (ii) aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl-transferase (gamma-GT) (liver injury and dysfunction), (iii) lipase (pancreatic injury) and (iv) creatine kinase (CK) (neuromuscular injury) (n=10). Administration (5 min prior to resuscitation of 5-AIQ) (0.03 mg kg(-1) i.v., n=8, or 0.3 mg kg(-1) i.v., n=10) reduced (in a dose-related fashion) the multiple organ injury and dysfunction, but did not affect the circulatory failure, associated with haemorrhagic shock. Thus, 5-AIQ abolishes the multiple organ injury caused by severe haemorrhage and resuscitation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864891      PMCID: PMC1572143          DOI: 10.1038/sj.bjp.0703391

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock.

Authors:  H Mota-Filipe; M C McDonald; S Cuzzocrea; C Thiemermann
Journal:  Shock       Date:  1999-10       Impact factor: 3.454

2.  DNA strand breaks, NAD metabolism, and programmed cell death.

Authors:  D A Carson; S Seto; D B Wasson; C J Carrera
Journal:  Exp Cell Res       Date:  1986-06       Impact factor: 3.905

3.  Oxidation and Claisen condensation products of 3-nitro-o-xylene.

Authors:  V Askam; R H Keeks
Journal:  J Chem Soc Perkin 1       Date:  1969

Review 4.  ADP-ribosylation.

Authors:  K Ueda; O Hayaishi
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

5.  Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock.

Authors:  M C McDonald; H M Filipe; C Thiemermann
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 6.  Oxygen-derived free radicals in postischemic tissue injury.

Authors:  J M McCord
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

7.  Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress.

Authors:  P K Chatterjee; S Cuzzocrea; C Thiemermann
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

8.  Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide.

Authors:  I U Schraufstatter; D B Hinshaw; P A Hyslop; R G Spragg; C G Cochrane
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

Review 9.  Poly(ADP-ribose) in the cellular response to DNA damage.

Authors:  N A Berger
Journal:  Radiat Res       Date:  1985-01       Impact factor: 2.841

10.  Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) synthetase in bovine tissues.

Authors:  K Ikai; K Ueda
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

View more
  14 in total

1.  5-Aminoisoquinolinone reduces colon injury by experimental colitis.

Authors:  Salvatore Cuzzocrea; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Nimesh S A Patel; Carmelo Muià; Michael D Threadgill; Angelina De Sarro; Christoph Thiemermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-18       Impact factor: 3.000

2.  Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress.

Authors:  Katalin Módis; Domokos Gero; Katalin Erdélyi; Petra Szoleczky; Douglas DeWitt; Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2011-12-16       Impact factor: 5.858

3.  Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.

Authors:  J P Roesner; D A Vagts; T Iber; C Eipel; B Vollmar; G F E Nöldge-Schomburg
Journal:  Intensive Care Med       Date:  2006-08-23       Impact factor: 17.440

4.  Characterization of human brain nicotinamide 5'-mononucleotide adenylyltransferase-2 and expression in human pancreas.

Authors:  Joel A Yalowitz; Suhong Xiao; Mangatt P Biju; Aśok C Antony; Oscar W Cummings; Mark A Deeg; Hiremagalur N Jayaram
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

5.  Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells.

Authors:  Li Cai; Michael D Threadgill; Yalan Wang; Ming Li
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 6.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 7.  The potential of PARP inhibitors in neuro-oncology.

Authors:  Ross Carruthers; Anthony J Chalmers
Journal:  CNS Oncol       Date:  2012-09

Review 8.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

9.  Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis.

Authors:  Francisco J Quintana; Mauricio F Farez; Vissia Viglietta; Antonio H Iglesias; Yifat Merbl; Guillermo Izquierdo; Miguel Lucas; Alexandre S Basso; Samia J Khoury; Claudia F Lucchinetti; Irun R Cohen; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

10.  PARP-1 regulates expression of TGF-β receptors in T cells.

Authors:  Pin Zhang; Hiroko Nakatsukasa; Eric Tu; Shimpei Kasagi; Kairong Cui; Masaki Ishikawa; Joanne E Konkel; Takashi Maruyama; Gang Wei; Brittany Abbatiello; Zhao-Qi Wang; Keji Zhao; WanJun Chen
Journal:  Blood       Date:  2013-08-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.